In Asia, premium beer volume also grew mid-single-digit while India has seen particular momentum: the premium portfolio, led ...

Citi believes aficamten will have a superior label and less burdensome prescribing requirements relative to Bristol’s (BMY) Camzyos, allowing it to become the option of choice. Pressure on ...

arguing that it will become the “option of choice” with a superior label and less stringent prescribing requirements.

Targeting the lowest performers may be logical for the companies' bottom lines, but the publicity surrounding layoffs can give those a negative label that can compound the difficulties of being ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

DiveWire guarantees visibility for your news announcements through instant distribution to Marketing Dive’s audience and its 270,500 newsletter subscribers for 21 days.